Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Work Comp: COVID-19 Effects and Lasting Impacts [Podcast]
On-Demand
In this podcast series, Mitchell | Genex subject matter experts from across the business share their expertise on how the COVID-19 pandemic is affe
Webcast: Workers’ Compensation Legislation Addressing Essential Workers Affected by COVID-19
On-Demand
As the United States continues to battle COVID-19, many states have taken emergency legislative and regulatory actions to address potential issues
Business Insurance: Assaults complicate comp claims
As workplace violence rates in the retail and restaurant industries continue to rise, workers compensation experts say claims arising from su
Exceeding Expectations…We Are All Consumers
A long-held belief exists that “the customer is always right” and whether or not you believe this to be accurate, we can likely agree that always b
Aging Workforce, Medication Safety and Cyber Security in the Workers’ Compensation Industry
On-Demand
Want to learn more about how your organization can manage the aging workforce, medication safety and cyber security?
Looking Ahead: 2020 Workers’ Compensation Predictions
The new decade has arrived and we are taking a look ahead at the regulatory and compliance trends we expect to hit the workers’ compensation market